SR-9011 (1 Gram Powder)
SR-9011 vs SR-9009
SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues
SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration = 790 nM for Rev-Erbα and IC₅₀ = 560 nM for Rev-ErbAβ.
FrankDec 16, 2019, 13:41This stuff kicks ass, way better than sr9009 which is awesome anyways